These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D. Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664 [Abstract] [Full Text] [Related]
9. Reversible acute kidney injury (AKI) by active removal of serum light chains in an HIV positive patient with myeloma kidney. Sowole L, Burns A, Kaur B, Davenport A. Clin Nephrol; 2011 Nov; 76(5):417-20. PubMed ID: 22000564 [Abstract] [Full Text] [Related]
16. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. J Am Soc Nephrol; 2007 Mar; 18(3):886-95. PubMed ID: 17229909 [Abstract] [Full Text] [Related]
20. Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney. Grima DT, Airia P, Attard C, Hutchison CA. Curr Med Res Opin; 2011 Feb; 27(2):383-91. PubMed ID: 21175375 [Abstract] [Full Text] [Related] Page: [Next] [New Search]